Around 90% of the drug molecules in the discovery pipeline are insoluble.

Amorphous dispersions prepared by spray drying are a growing approach to improve the solubility of many poorly soluble molecules.

In addition to enhancing bioavailability, spray drying is a robust and scalable process and can result in solid dosage form. Watch the short video to get expert insight on successful spray drying process for clinical and commercial production.